Interestingly, while HSP90 is required for the stabilization of a number of oncogenes28, our findings suggest that the expression of its upstream regulator USP22 displays a dichotomous relationship with tumor progression where high USP22 expression correlates with unfavorable prognosis in breast cancer but improved survival in rectal cancer patients. The gene discussed is USP22; the disease is breast carcinoma.